Journal Article: Outcomes of artery embolisation for cystic fibrosis patients with haemoptysis: a 20-year experience at a major Australian tertiary centre
Semasinghe Bandaralage, Sahan P., Tay, George, Hay, Karen, Megram, Emma, Smith, Daniel, Gadowski, Tahlia, Wright, Eimear, France, Megan, Bell, Scott and Reid, David (2021). Outcomes of artery embolisation for cystic fibrosis patients with haemoptysis: a 20-year experience at a major Australian tertiary centre. Internal Medicine Journal, 51 (9), 1526-1529. doi: 10.1111/imj.15483
Journal Article: Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung disease
Tong, Koliarne, Barker, Daniel, France, Megan, Burr, Lucy, Greville, Hugh, Visser, Simone, Middleton, Peter, Wainwright, Claire, Dorahy, Douglas and Wark, Peter (2019). Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung disease. Journal of Cystic Fibrosis, 19 (3), 415-420. doi: 10.1016/j.jcf.2019.12.006
Journal Article: Ivacaftor in severe cystic fibrosis lung disease and a G551D mutation
Wood, Michelle E., Smith, Daniel J., Reid, David W., Masel, Philip J., France, Megan W. and Bell, Scott C. (2013). Ivacaftor in severe cystic fibrosis lung disease and a G551D mutation. Respirology Case Reports, 1 (2), 52-54. doi: 10.1002/rcr2.27
Semasinghe Bandaralage, Sahan P., Tay, George, Hay, Karen, Megram, Emma, Smith, Daniel, Gadowski, Tahlia, Wright, Eimear, France, Megan, Bell, Scott and Reid, David (2021). Outcomes of artery embolisation for cystic fibrosis patients with haemoptysis: a 20-year experience at a major Australian tertiary centre. Internal Medicine Journal, 51 (9), 1526-1529. doi: 10.1111/imj.15483
Tong, Koliarne, Barker, Daniel, France, Megan, Burr, Lucy, Greville, Hugh, Visser, Simone, Middleton, Peter, Wainwright, Claire, Dorahy, Douglas and Wark, Peter (2019). Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung disease. Journal of Cystic Fibrosis, 19 (3), 415-420. doi: 10.1016/j.jcf.2019.12.006
Ivacaftor in severe cystic fibrosis lung disease and a G551D mutation
Wood, Michelle E., Smith, Daniel J., Reid, David W., Masel, Philip J., France, Megan W. and Bell, Scott C. (2013). Ivacaftor in severe cystic fibrosis lung disease and a G551D mutation. Respirology Case Reports, 1 (2), 52-54. doi: 10.1002/rcr2.27
Tse, T., Hopkins, P. M. A., France, M. W., Masel, P. J., Bell, S. C., Kermeen, F. D. and Chambers, D. C. (2010). Antibiotic desensitisation in cystic fibrosis patients with a history of hypersensitivity undergoing lung transplantation is not mandatory. 30th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation, Chicago Il, Apr 21-24, 2010. ELSEVIER SCIENCE INC.